Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender

PURPOSE OF REVIEW: Over the last decades, several classes of drugs have been introduced for the treatment of patients with heart failure with reduced ejection fraction (HFrEF). Their use has been supported by randomized controlled trials that have demonstrated improved patient outcomes. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacoviello, Massimo, Pugliese, Rosanna, Correale, Michele, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Heart Failure (T.E. Meyer, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653313/
https://www.ncbi.nlm.nih.gov/pubmed/36197626
http://dx.doi.org/10.1007/s11897-022-00583-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653313/
https://www.ncbi.nlm.nih.gov/pubmed/36197626
http://dx.doi.org/10.1007/s11897-022-00583-w

Ejemplares similares